These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23640888)

  • 121. Methadone Blockade of Cardiac Inward Rectifier K
    Klein MG; Krantz MJ; Fatima N; Watters A; Colon-Sanchez D; Geiger RM; Goldstein RE; Solhjoo S; Mehler PS; Flagg TP; Haigney MC
    J Am Heart Assoc; 2022 Jun; 11(11):e023482. PubMed ID: 35658478
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations.
    Benzoni P; Gazzerro E; Fiorillo C; Baratto S; Bartolucci C; Severi S; Milanesi R; Lippi M; Langione M; Murano C; Meoni C; Popolizio V; Cospito A; Baruscotti M; Bucchi A; Barbuti A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256054
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Proteomic Analysis of the Functional Inward Rectifier Potassium Channel (Kir) 2.1 Reveals Several Novel Phosphorylation Sites.
    Brown KA; Anderson C; Reilly L; Sondhi K; Ge Y; Eckhardt LL
    Biochemistry; 2021 Nov; 60(44):3292-3301. PubMed ID: 34676745
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms.
    He M; Qiu J; Wang Y; Bai Y; Chen G
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329921
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels.
    Delgado-Ramírez M; Rodriguez-Leal FJ; Rodríguez-Menchaca AA; Moreno-Galindo EG; Sanchez-Chapula JA; Ferrer T
    Acta Pharm; 2021 Jun; 71(2):317-324. PubMed ID: 33151169
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Caveolae regulation of mechanosensitive channel function in myotubes.
    Huang H; Bae C; Sachs F; Suchyna TM
    PLoS One; 2013; 8(8):e72894. PubMed ID: 24023653
    [TBL] [Abstract][Full Text] [Related]  

  • 127. ESCRT regulates surface expression of the Kir2.1 potassium channel.
    Kolb AR; Needham PG; Rothenberg C; Guerriero CJ; Welling PA; Brodsky JL
    Mol Biol Cell; 2014 Jan; 25(2):276-89. PubMed ID: 24227888
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Caveolin-3 loss linked with the P104L LGMD-1C mutation modulates skeletal muscle mTORC1 signalling and cholesterol homeostasis.
    Shah DS; Nisr RB; Krasteva-Christ G; Hundal HS
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2310-2326. PubMed ID: 37671684
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Golgin-97 Targets Ectopically Expressed Inward Rectifying Potassium Channel, Kir2.1, to the
    Taneja TK; Ma D; Kim BY; Welling PA
    Front Physiol; 2018; 9():1070. PubMed ID: 30123141
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Overexpression of microRNA-1 causes atrioventricular block in rodents.
    Zhang Y; Sun L; Zhang Y; Liang H; Li X; Cai R; Wang L; Du W; Zhang R; Li J; Wang Z; Ma N; Wang X; Du Z; Yang B; Gao X; Shan H
    Int J Biol Sci; 2013; 9(5):455-62. PubMed ID: 23678295
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Caveolin modulates integrin function and mechanical activation in the cardiomyocyte.
    Israeli-Rosenberg S; Chen C; Li R; Deussen DN; Niesman IR; Okada H; Patel HH; Roth DM; Ross RS
    FASEB J; 2015 Feb; 29(2):374-84. PubMed ID: 25366344
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Quantitative Analysis of the Cytoskeleton's Role in Inward Rectifier K
    Li E; Loen V; van Ham WB; Kool W; van der Heyden MAG; Takanari H
    Front Physiol; 2021; 12():812572. PubMed ID: 35145427
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Mechanisms of Cav3-associated arrhythmia: Protein or microdomain dysfunction?
    Zaza A; Grandi E
    Int J Cardiol; 2020 Dec; 320():97-99. PubMed ID: 32634502
    [No Abstract]   [Full Text] [Related]  

  • 134. Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba
    Iijima A; Švecová O; Hošek J; Kula R; Bébarová M
    Front Pharmacol; 2023; 14():1136272. PubMed ID: 36817146
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Chronic Propafenone Application Increases Functional K
    Li E; Kool W; Woolschot L; van der Heyden MAG
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986503
    [TBL] [Abstract][Full Text] [Related]  

  • 136. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells.
    Van de Sande DV; Kopljar I; Maaike A; Teisman A; Gallacher DJ; Bart L; Snyders DJ; Leybaert L; Lu HR; Labro AJ
    Channels (Austin); 2021 Dec; 15(1):239-252. PubMed ID: 33465001
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Targeting caveolin-3 for the treatment of diabetic cardiomyopathy.
    Murfitt L; Whiteley G; Iqbal MM; Kitmitto A
    Pharmacol Ther; 2015 Jul; 151():50-71. PubMed ID: 25779609
    [TBL] [Abstract][Full Text] [Related]  

  • 138. The network of cardiac K
    Li E; van der Heyden MAG
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38683369
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Kir2.1-mediated membrane potential promotes nutrient acquisition and inflammation through regulation of nutrient transporters.
    Yu W; Wang Z; Yu X; Zhao Y; Xie Z; Zhang K; Chi Z; Chen S; Xu T; Jiang D; Guo X; Li M; Zhang J; Fang H; Yang D; Guo Y; Yang X; Zhang X; Wu Y; Yang W; Wang D
    Nat Commun; 2022 Jun; 13(1):3544. PubMed ID: 35729093
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Determinants of trafficking, conduction, and disease within a K
    Coyote-Maestas W; Nedrud D; He Y; Schmidt D
    Elife; 2022 May; 11():. PubMed ID: 35639599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.